Ausgabe 3/2011
Inhalt (36 Artikel)
“Overcoming breast cancer drug resistance with mTOR inhibitors”. Could it be a myth or a real possibility in the short-term future?
Nadia Margariti, Stephen B. Fox, Alberto Bottini, Daniele Generali
Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?
Bernd Gerber, Kristin Heintze, Johannes Stubert, Max Dieterich, Steffi Hartmann, Angrit Stachs, Toralf Reimer
Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials
Wen-Bin Zhou, Qiang Ding, Ling Chen, Xiao-An Liu, Shui Wang
Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients
Yasuto Naoi, Kazuki Kishi, Tomonori Tanei, Ryo Tsunashima, Naoomi Tominaga, Yosuke Baba, Seung Jin Kim, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi
Time to move forward from “first-generation” prognostic gene signatures in early breast cancer
Christine Desmedt, Stefan Michiels, Benjamin Haibe-Kains, Sherene Loi, Christos Sotiriou
Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer
Cha Kyong Yom, Dong-Young Noh, Woo Ho Kim, Hee Sung Kim
The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system
Eliza Wiercinska, Hildegonda P. H. Naber, Evangelia Pardali, Gabri van der Pluijm, Hans van Dam, Peter ten Dijke
The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor
Yuxin Li, Qiang Shen, Hee-Tae Kim, Reid P. Bissonnette, William W. Lamph, Bingfang Yan, Powel H. Brown
Image-guided tumor resection using real-time near-infrared fluorescence in a syngeneic rat model of primary breast cancer
J. Sven D. Mieog, Merlijn Hutteman, Joost R. van der Vorst, Peter J. K. Kuppen, Ivo Que, Jouke Dijkstra, Eric L. Kaijzel, Frans Prins, Clemens W. G. M. Löwik, Vincent T. H. B. M. Smit, Cornelis J. H. van de Velde, Alexander L. Vahrmeijer
Anti-tissue factor short hairpin RNA inhibits breast cancer growth in vivo
J. E. Bluff, M. Amarzguioui, J. Slattery, M. W. R. Reed, N. J. Brown, C. A. Staton
Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome
Michael J. Campbell, Nathan Y. Tonlaar, Elisabeth R. Garwood, Dezheng Huo, Dan H. Moore, Andrey I. Khramtsov, Afred Au, Frederick Baehner, Yinghua Chen, David O. Malaka, Amy Lin, Oyinlolu O. Adeyanju, Shihong Li, Can Gong, Michael McGrath, Olufunmilayo I. Olopade, Laura J. Esserman
Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
Gizeh Pérez-Tenorio, Elin Karlsson, Marie Ahnström Waltersson, Birgit Olsson, Birgitta Holmlund, Bo Nordenskjöld, Tommy Fornander, Lambert Skoog, Olle Stål
The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study
E. J. Macaskill, J. M. S. Bartlett, V. S. Sabine, D. Faratian, L. Renshaw, S. White, F. M. Campbell, O. Young, L. Williams, J. S. Thomas, M. D. Barber, J. M. Dixon
Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery
Naruto Taira, Kojiro Shimozuma, Takeru Shiroiwa, Shozo Ohsumi, Katsumasa Kuroi, Shigehira Saji, Mitsue Saito, Shigemichi Iha, Takanori Watanabe, Noriyuki Katsumata
Occult breast carcinoma in breast reduction specimens in European women
Amit Goyal, Samuel G. Coulson, Jessie M. Wu, Simon Kim Suvarna, Malcolm W. R. Reed, Christopher M. Caddy
Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer
Asgerdur Sverrisdottir, Hemming Johansson, Ulla Johansson, Jonas Bergh, Samuel Rotstein, LarsErik Rutqvist, Tommy Fornander
A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients
Seung Jin Kim, Akinori Masago, Yasuhiro Tamaki, Kenji Akazawa, Fumine Tsukamoto, Jun Sato, Toshiyuki Ozawa, Yukio Tsujino, Shinzaburo Noguchi
Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor–positive breast cancer: the results of a 2-year multicenter open randomized study
Keisei Anan, Shoshu Mitsuyama, Yasuhiro Yanagita, Morihiko Kimura, Hiroyoshi Doihara, Kansei Komaki, Mikihiro Kusama, Tadashi Ikeda
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
Sirwan Hadad, Takayuki Iwamoto, Lee Jordan, Colin Purdie, Susan Bray, Lee Baker, Gera Jellema, Steve Deharo, D. Grahame Hardie, Lajos Pusztai, Stacy Moulder-Thompson, John A. Dewar, Alastair M. Thompson
Unfavourable pattern of metastases in M0 breast cancer patients during 1978-2008: a population-based analysis of the Munich Cancer Registry
Corina J. G. van den Hurk, Renate Eckel, Lonneke V. van de Poll-Franse, Jan Willem W. Coebergh, Johan W. R. Nortier, Dieter Hölzel, Wim P. M. Breed, Jutta Engel
Trends in improving survival in breast cancer: two steps forward but one step back?
Stephen Chia
Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis
Wei Zheng, Xiu-Feng Cong, Wei-Hao Cai, Sheng Yang, Chen Mao, Hua-Wei Zou
Alcohol consumption and breast cancer risk in Japanese women: The Miyagi Cohort Study
Masaaki Kawai, Yuko Minami, Masako Kakizaki, Yoichiro Kakugawa, Yoshikazu Nishino, Akira Fukao, Ichiro Tsuji, Noriaki Ohuchi
Improved web-based calculators for predicting breast carcinoma outcomes
James S. Michaelson, L. Leon Chen, Devon Bush, Allan Fong, Barbara Smith, Jerry Younger
Urinary cadmium and mammographic density in premenopausal women
Scott V. Adams, Polly A. Newcomb, Martin M. Shafer, Charlotte Atkinson, Erin J. Aiello Bowles, Katherine M. Newton, Johanna W. Lampe
Genomic rearrangements of the BRCA1 gene in Chilean breast cancer families: an MLPA analysis
Alejandro Sanchez, Paola Faundez, Pilar Carvallo
Genetic variants in ultraconserved elements and risk of breast cancer in Chinese population
Hao Shen, Cheng Lu, Yue Jiang, Jinhai Tang, Wei Chen, Hanze Zhang, Qin Zhang, Jianming Wang, Jie Liang, Zhibin Hu, Hongbing Shen
Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer
Katherine E. Reeder-Hayes, John Bainbridge, Anne Marie Meyer, Keith D. Amos, Bryan J. Weiner, Paul A. Godley, William R. Carpenter
A nationwide analysis of incidence and outcome of breast cancer in the country of Surinam, during 1994–2003
Rachel S. van Leeuwaarde, Martinus A. Vrede, Floyd Henar, Rob Does, Philip Issa, Emmett Burke, Otto Visser, Frank Rijmen, Anneke M. Westermann
Prediagnostic plasma enterolactone levels and mortality among women with breast cancer
Anja Olsen, Jane Christensen, Knud Erik Bach Knudsen, Nina Føns Johnsen, Kim Overvad, Anne Tjønneland
Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient
M. Ángeles Villaronga, Irene López-Mateo, Linn Markert, Enrique Espinosa, Juan Ángel Fresno Vara, Borja Belandia
Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation
J. E. Panoff, J. Hurley, C. Takita, I. M. Reis, W. Zhao, V. Sujoy, C. R. Gomez, M. Jorda, L. Koniaris, J. L. Wright
Low vitamin D status likely contributes to the link between periodontal disease and breast cancer
William B. Grant, Barbara J. Boucher
Revaluation of the association between vascular endothelial growth factor gene 936 C/T polymorphism and breast cancer risk
Bo Jin, Fusheng Jiang, Zhishan Ding
The association between IGF1 CA repeat polymorphisms and breast cancer risk: appraisal of a recent meta-analysis
Yan-Feng Zou, Fang Wang, Xiao-Liang Feng